ENO1 and hepatocellular carcinoma: Four of these 10 genes (outlined in yellow in Table S6), i.e., enolase 1 (Eno1), pyruvate kinase L/R (Pklr), fatty acid binding protein 1 (Fabp1), and perilipin 2 (Plin2), are key relevant actors in the hepatic glucose/lipid metabolism and are also reported to promote HCC development [52,53,54,55].